Finance

Beta
Lists
006620:KOSDAQ
DongKoo Bio & Pharma Co Ltd
â‚©3,770.00
+0.27%
(+10.00) 1D
Jun 25, 3:30:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 006620...
Open
â‚©3,730
High
â‚©3,930
Low
â‚©3,675
Mkt. cap
107.31B
Avg. vol.
347.86K
Volume
67.17K
Dividend
3.18%
Quarterly dividend
â‚©30
Ex-dividend date
Dec 27, 2024
P/E ratio
2.05
52-wk high
â‚©6,390
52-wk low
â‚©3,665
EPS
â‚©1,842
Shares outstanding
28.46M
No. of employees
404
Open
â‚©3,730
High
â‚©3,930
Low
â‚©3,675
Mkt. cap
107.31B
Avg. vol.
347.86K
Volume
67.17K
Dividend
3.18%
Quarterly dividend
â‚©30
Ex-dividend date
Dec 27, 2024
P/E ratio
2.05
52-wk high
â‚©6,390
52-wk low
â‚©3,665
EPS
â‚©1,842
Shares outstanding
28.46M
No. of employees
404
News stories
From sources across the web
About DongKoo Bio & Pharma Co Ltd
CEO-
Employees404
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitedongkoo.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
60.12B
62.02B
61.87B
58.06B
Cost of goods sold
23.57B
25.77B
26.33B
23.46B
Cost of revenue
23.57B
25.77B
26.33B
23.46B
Research and development expenses
2.99B
2.45B
3.14B
2.89B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.31B
31.30B
29.21B
29.59B
Operating expense
34.62B
34.06B
32.74B
32.80B
Total operating expenses
58.19B
59.83B
59.08B
56.26B
Operating income
1.93B
2.19B
2.80B
1.81B
Other non operating income
-737.69M
8.94M
17.20B
-4.35B
EBT including unusual items
11.86B
-1.04B
51.54B
-599.20M
EBT excluding unusual items
1.20B
1.29B
19.20B
-3.32B
Income tax expense
564.89M
584.39M
10.31B
-21.28M
Effective tax rate
4.76%
-56.25%
20.01%
3.55%
Other operating expenses
77.61M
59.89M
47.24M
123.62M
Net income
11.29B
-1.62B
41.27B
-577.34M
Net profit margin
18.79%
-2.60%
66.71%
-0.99%
Earnings per share
-
-
-
-
Interest and investment income
30.43M
20.90M
28.15M
63.80M
Interest expense
-868.77M
-947.86M
-802.30M
-1.01B
Net interest expenses
-838.34M
-926.96M
-774.15M
-947.00M
Depreciation and amortization charges
204.37M
165.96M
208.57M
214.31M
EBITDA
4.28B
4.41B
4.98B
3.75B
Gain or loss from assets sale
-
-
-3.63M
-16.46M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer